S&P 및 Nasdaq 내재가치 문의하기

Insulet Corporation PODD NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
74/100
4/7 Pass
SharesGrow Intrinsic Value
$321.45
+59.5%
Analyst Price Target
$357.25
+77.3%

Insulet Corporation (PODD) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Devices 산업에서 운영. 본사 소재지는 Acton, MA, 미국. 현재 CEO는 Ashley A. McEvoy.

PODD 을(를) 보유 IPO 날짜 2007-05-15, 5,400 명의 정규직 직원, 에 상장 NASDAQ Global Select, 시가총액 $14.18B.

Insulet Corporation 소개

Insulet Corporation is a medical device company that develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's flagship product is the Omnipod System, a tubeless, self-adhesive disposable insulin pump worn on the body for up to three days, controlled wirelessly by a handheld personal diabetes manager. Insulet distributes its products through independent distributors, pharmacy channels, and direct sales across the United States, Canada, Europe, the Middle East, and Australia. Founded in 2000 and headquartered in Acton, Massachusetts, the company serves a global market of insulin-dependent diabetes patients seeking convenient, modern insulin delivery solutions.

📍 100 Nagog Park, Acton, MA 01720 📞 978 600 7000
회사 세부정보
섹터헬스케어
산업Medical - Devices
국가미국
거래소NASDAQ Global Select
통화USD
IPO 날짜2007-05-15
CEOAshley A. McEvoy
직원 수5,400
거래 정보
현재 가격$201.49
시가역액$14.18B
52주 범위202.44-354.88
베타1.47
ETF아니오
ADR아니오
CUSIP45784P101
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기